mesenchymal chondrosarcoma
In conclusion, molecular profiling of mesenchymal chondrosarcoma using a proteomic approach characterized the mesenchymal chondroblasts as possessing pathways that incorporate PKC-alpha and PDGFR-alpha signaling and anti-apoptotic bcl-2 expression.
In conclusion, molecular profiling of <span class="disease" id="12817616-5-38-64">mesenchymal chondrosarcoma</span> using a proteomic approach characterized the mesenchymal chondroblasts as possessing pathways that incorporate PKC-alpha and PDGFR-alpha signaling and anti-apoptotic <span class="gene" id="12817616-5-231-236">bcl-2</span> expression.